Literature DB >> 32111021

Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver.

Toshihiro Niikura1,2, Kento Imajo1, Anna Ozaki1, Takashi Kobayashi1, Michihiro Iwaki1, Yasushi Honda1, Takaomi Kessoku1, Yuji Ogawa1, Masato Yoneda1, Hiroyuki Kirikoshi3, Satoru Saito1, Atsushi Nakajima1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is associated with a higher risk of atherosclerotic disease. However, the relationships between the severity of coronary atherosclerosis and pathologic findings in patients with NAFLD remain unknown. We aimed to characterize the coronary artery lesions in patients with NAFLD using coronary computed tomography angiography (CCTA). Overall, 101 patients with liver biopsy-proven NAFLD who had chest pain or electrocardiographic abnormalities underwent CCTA. Coronary artery lesions, including coronary artery stenosis (CAS), calcium score (CACS, Agatston score), and coronary artery non-calcified plaque were assessed using multi-slice CT. Multivariate analysis showed that age, smoking status, prevalence of dyslipidemia (DLP) and non-alcoholic steatohepatitis (NASH), and stage of fibrosis were independent risk factors for CAS. Age, and the prevalence of DM and DLP, were independent risk factors for CACS, and the prevalence of NASH tended to be an independent risk factor. In addition, the prevalence of DLP and NASH were independent risk factors for non-calcified plaques. Coronary artery lesions are more common in patients with NASH than in those with non-alcoholic fatty liver, suggesting a higher risk in patients with NASH. Therefore, patients with NASH should be closely followed, with particular vigilance for coronary artery diseases.

Entities:  

Keywords:  Agatston score.; coronary CT angiography; coronary artery lesion; non-alcoholic fatty liver; non-alcoholic steatohepatitis

Year:  2020        PMID: 32111021     DOI: 10.3390/diagnostics10030129

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  7 in total

1.  Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.

Authors:  Jung Gil Park; Jinho Jung; Kritin K Verma; Min Kyu Kang; Egbert Madamba; Scarlett Lopez; Aed Qas Yonan; Amy Liu; Ricki Bettencourt; Claude Sirlin; Rohit Loomba
Journal:  Aliment Pharmacol Ther       Date:  2021-03-25       Impact factor: 8.171

2.  Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.

Authors:  Chia-Chi Hsiao; Pai-Hsueh Teng; Yun-Ju Wu; Yi-Wen Shen; Guang-Yuan Mar; Fu-Zong Wu
Journal:  BMC Cardiovasc Disord       Date:  2021-05-19       Impact factor: 2.298

3.  Identification of Serum Oxylipins Associated with the Development of Coronary Artery Disease: A Nested Case-Control Study.

Authors:  Kuang-Mao Chiang; Jia-Fu Chen; Chin-An Yang; Lili Xiu; Hsin-Chou Yang; Lie-Fen Shyur; Wen-Harn Pan
Journal:  Metabolites       Date:  2022-05-30

4.  Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia.

Authors:  Giuseppe Mandraffino; Carmela Morace; Maria Stella Franzè; Veronica Nassisi; Davide Sinicropi; Maria Cinquegrani; Carlo Saitta; Riccardo Scoglio; Sebastiano Marino; Alessandra Belvedere; Valentina Cairo; Alberto Lo Gullo; Michele Scuruchi; Giovanni Raimondo; Giovanni Squadrito
Journal:  Biomedicines       Date:  2022-07-22

Review 5.  New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis.

Authors:  Georgiana-Diana Cazac; Cristina-Mihaela Lăcătușu; Cătălina Mihai; Elena-Daniela Grigorescu; Alina Onofriescu; Bogdan-Mircea Mihai
Journal:  Life (Basel)       Date:  2022-08-04

Review 6.  Relationship between non-alcoholic fatty liver disease and coronary heart disease.

Authors:  Ugur Arslan; Mustafa Yenerçağ
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

Review 7.  Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?

Authors:  Adonis A Protopapas; Evangelos Cholongitas; Lampros Chrysavgis; Konstantinos Tziomalos
Journal:  Ann Gastroenterol       Date:  2021-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.